New review highlights prognostic and mechanistic roles of secretoneurin in cardiovascular disease

A review published in Expert Review of Cardiovascular Therapy discusses the emerging role of secretoneurin as a potential prognostic biomarker in cardiovascular disease. The authors report that circulating secretoneurin levels may provide prognostic information beyond established cardiovascular biomarkers.
The review highlights that these findings support the potential of secretoneurin in cardiovascular risk assessment, although its clinical utility and specific applications remain to be established.
In addition, the article summarizes experimental and preclinical evidence linking secretoneurin to several pathophysiological pathways relevant to cardiovascular disease.
Overall, the authors emphasize that secretoneurin is a promising biomarker with both prognostic and mechanistic relevance, but that further studies are needed to clarify its biological role and determine its value in clinical practice.
For CardiNor, the review reinforces the growing scientific interest in secretoneurin and the importance of reliable biomarker measurements in cardiovascular research.

Figure adapted from Ottesen et al. (2026), Expert Review of Cardiovascular Therapy. Modified for clarity and visual presentation.
Link to review article:
https://www.tandfonline.com/doi/full/10.1080/14779072.2025.2604574



